86. 肺動脈性肺高血圧症 Pulmonary arterial hypertension Clinical trials / Disease details
臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02304198 (ClinicalTrials.gov) | April 2014 | 26/11/2014 | Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH | A Single-arm, Open-label, Extension Study to Evaluate the Long-term Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) | Pulmonary Arterial Hypertension | Drug: Udenafil | Dong-A ST Co., Ltd. | NULL | Completed | 18 Years | N/A | Both | 59 | Phase 2/Phase 3 | Korea, Republic of |
2 | NCT01553721 (ClinicalTrials.gov) | August 2011 | 1/1/2012 | Efficacy and Safety Study of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) | A Placebo-controlled, Double-blind, Phase II Clinical Study to Evaluate the Efficacy and Safety of Udenafil in Patient With Pulmonary Arterial Hypertension(PAH) | Pulmonary Arterial Hypertension | Drug: udenafil;Drug: placebo | Dong-A ST Co., Ltd. | NULL | Completed | 18 Years | N/A | Both | 63 | Phase 2 | Korea, Republic of |